![Karl Hård](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karl Hård
Investor Relations Contact bij
EGETIS THERAPEUTICS AB
Vermogen: 99 420 $ op 31-05-2026
Profiel
Karl J.
Hård is currently VP-Investor Relations & Business Development at Egetis Therapeutics AB since 2022.
Former positions include Investor Relations Contact at AstraZeneca PLC, Assistant Professor at the University of Leiden, Head-Investor Relations & Corporate Communications at Redx Pharma Plc from 2016 to 2017, and Head-Investor Relations & Communications at Kiadis Pharma NV from 2017 to 2018.
Education includes a doctorate from the University of Utrecht and graduate studies at the University of Helsinki.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-12-2025 | 150.982 ( 0,03% ) | 99 420 $ | 31-05-2026 |
Actieve functies van Karl Hård
| Bedrijven | Functie | Begin |
|---|---|---|
| EGETIS THERAPEUTICS AB | Investor Relations Contact | 01-02-2022 |
Eerdere bekende functies van Karl Hård
| Bedrijven | Functie | Einde |
|---|---|---|
| KIADIS PHARMA N.V. | Investor Relations Contact | 31-12-2018 |
| REDX PHARMA LTD | Investor Relations Contact | 02-07-2017 |
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| ASTRAZENECA PLC | Public Communications Contact | - |
Opleiding van Karl Hård
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
13
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Utrecht
 University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Helsinki
 University of Helsinki Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Egetis Therapeutics AB
 Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Redx Pharma Plc
 Redx Pharma Plc Pharmaceuticals: MajorHealth Technology Discovers and develops novel, small molecule & targeted therapeutics for treatment of cancer and fibrotic disease | Health Technology |
Kiadis Pharma NV
 Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company focused on research, development and commercialization of cell based immunotherapy products | Health Technology |
